Esperal: A Clinically Proven Aid for Alcohol Dependence Management
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.03 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $82.06 $66.05 (20%) | 🛒 Add to cart |
| 90 | $1.01 | $123.09 $91.07 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $164.12 $117.08 (29%) | 🛒 Add to cart |
| 180 | $0.93 | $246.18 $168.12 (32%) | 🛒 Add to cart |
| 270 | $0.90 | $369.27 $243.18 (34%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $492.36 $317.23 (36%) | 🛒 Add to cart |
Synonyms | |||
Esperal (disulfiram) is a prescription medication designed to support the treatment of chronic alcohol dependence by creating a physiological deterrent to alcohol consumption. It functions as an aversive therapy agent, inducing an unpleasant reaction when alcohol is ingested, thereby helping patients maintain abstinence as part of a comprehensive treatment plan that includes counseling and psychosocial support. Administered under strict medical supervision, Esperal is indicated for motivated patients committed to achieving long-term sobriety. Its use requires thorough patient education, informed consent, and regular monitoring to ensure safety and efficacy within a structured therapeutic framework.
Features
- Active ingredient: Disulfiram
- Available in 250 mg and 500 mg oral tablets
- Long-acting effect; reaction can occur up to 14 days after discontinuation
- Requires once-daily administration
- Must be prescribed and monitored by a healthcare professional
- Works via irreversible inhibition of aldehyde dehydrogenase (ALDH)
Benefits
- Supports abstinence by creating a strong psychological and physical deterrent to alcohol use
- Integrates seamlessly into multidisciplinary treatment programs including behavioral therapy
- Helps break the cycle of alcohol dependence by reducing relapse frequency
- Provides a tangible mechanism to reinforce commitment to sobriety
- Can contribute to improved liver function and overall health with sustained abstinence
- Empowers patients within a structured recovery plan
Common use
Esperal is used as an adjunct in the management of chronic alcohol dependence in patients who wish to maintain a state of enforced sobriety. It is suitable for motivated individuals who are concurrently participating in a supportive treatment program, such as counseling or cognitive behavioral therapy. Treatment is typically initiated only after the patient has abstained from alcohol for at least 12 hours and understands the consequences of alcohol consumption while on the medication. It is not intended for use as a standalone treatment and is most effective when embedded within a broader therapeutic strategy addressing the psychological and social aspects of addiction.
Dosage and direction
The initial dosage is typically 500 mg daily for the first one to two weeks, administered orally once per day. Maintenance doses generally range from 125 mg to 500 mg daily, tailored to individual tolerance and therapeutic response. Dosage should not exceed 500 mg per day. Tablets may be crushed and mixed with liquid if swallowing is difficult. Administration should occur in the morning to help reinforce daily compliance. Treatment must only begin under medical supervision after a period of confirmed alcohol abstinence. Regular follow-up is essential to assess efficacy and monitor for adverse effects.
Precautions
Patients must be fully informed of the disulfiram-ethanol reaction and explicitly consent to treatment. Liver function tests should be performed at baseline and periodically during therapy. Use with caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, or renal impairment. Avoid exposure to alcohol-containing products such as perfumes, aftershaves, mouthwashes, and some food preparations (e.g., vinegar, sauces). Caution is advised when operating machinery until the patient’s response to the drug is known. Not recommended for use in patients with severe cardiac or respiratory disease.
Contraindications
Esperal is contraindicated in patients with severe myocardial disease or coronary occlusion, psychosis, hypersensitivity to disulfiram or other thiuram derivatives, and those currently using or recently exposed to alcohol or alcohol-containing products. It is also contraindicated in patients with severe hepatic impairment or failure. Concomitant use with metronidazole, paraldehyde, or certain other drugs metabolized via cytochrome P450 is not recommended. Should not be administered during pregnancy or to nursing mothers unless the potential benefit justifies the potential risk.
Possible side effect
Common side effects may include drowsiness, fatigue, headache, metallic or garlic-like aftertaste, and skin eruptions. Less frequently, patients may experience peripheral neuropathy, optic neuritis, polyneuritis, hepatitis, or psychotic reactions. The disulfiram-ethanol reaction—characterized by flushing, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, hyperventilation, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion—may occur following alcohol ingestion. Severe reactions can include respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death.
Drug interaction
Concomitant use with alcohol or alcohol-containing medications will provoke a disulfiram-ethanol reaction. May increase serum levels of phenytoin, warfarin, benzodiazepines, tricyclic antidepressants, and theophylline due to inhibition of cytochrome P450 2C9 and other enzymes. Concurrent use with isoniazid may increase the risk of adverse neuropsychiatric effects. Use with metronidazole may cause confusion or psychotic reactions. May potentiate the sedative effects of CNS depressants. Caution is advised with drugs that may affect liver function.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time of the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Inform the healthcare provider if multiple doses are missed, as this may require re-evaluation of the treatment plan and a possible supervised restart.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, ataxia, seizures, lethargy, and in severe cases, coma. The disulfiram-ethanol reaction may be provoked if alcohol is consumed. There is no specific antidote. Treatment is supportive and symptomatic, including gastric lavage if presented early, and management of complications such as respiratory depression or cardiovascular instability. Hospitalization and intensive supportive care are required in cases of severe overdose.
Storage
Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light. Keep in the original container, tightly closed. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of any unused medication safely, in accordance with local regulations, to prevent misuse.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or changing your treatment plan. Do not disregard professional medical advice or delay seeking it because of something you have read here. The use of Esperal must be supervised by a physician. Individual responses to medication may vary.
Reviews
Clinical studies and patient reports indicate that Esperal can be highly effective in supporting alcohol abstinence when used as part of a comprehensive treatment program. Many patients and clinicians note its value as a psychological reinforcement tool. However, success is highly dependent on patient motivation, adherence, and integration with behavioral therapies. Some users report side effects such as drowsiness or metallic taste, which often diminish over time. Medical professionals emphasize that informed consent, patient education, and regular monitoring are critical to safe and effective use.